Anpario’s (ANP) “House Stock” Rating Reiterated at Shore Capital

Shore Capital restated their house stock rating on shares of Anpario (LON:ANP) in a research note released on Monday morning, Marketbeat reports.

Separately, Canaccord Genuity Group lifted their price target on Anpario from GBX 500 to GBX 550 and gave the stock a “buy” rating in a research report on Tuesday, October 21st. One equities research analyst has rated the stock with a Buy rating, According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of GBX 550.

Anpario Price Performance

Shares of ANP opened at GBX 492 on Monday. The firm has a market capitalization of £83.37 million, a PE ratio of 16.55 and a beta of 0.58. The company has a debt-to-equity ratio of 0.10, a current ratio of 6.15 and a quick ratio of 5.16. Anpario has a 1-year low of GBX 286 and a 1-year high of GBX 536.50. The company’s fifty day moving average price is GBX 487.62 and its 200-day moving average price is GBX 460.64.

Anpario Company Profile

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.